United States Animal Drug Compounding Market By Product (Anti-infective Agents, Anti-inflammatory Agents, Hormones & Substitutes, CNS Agents, Others), By Animal Type (Companion Animal, Livestock Animal), By Route of Administration (Oral, Injectable, Topical, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

May 2025 | 83 pages | ID: UEB7BDEA78D6EN
TechSci Research

Abstracts

Market Overview

The United States Animal Drug Compounding Market was valued at USD 491.26 million in 2024 and is projected treach USD 754.17 million by 2030, registering a CAGR of 7.38%. The market is expanding rapidly due ta rising demand for customized veterinary treatments. Both pet owners and veterinarians are increasingly turning tcompounded medications tailored tsuit specific species, sizes, and health needs. These customized solutions improve efficacy and compliance by offering precise dosages, flavors, and combinations that are not typically available in mass-market pharmaceuticals. Increased pet ownership, greater awareness of animal wellness, and frequent veterinary consultations are further fueling this growth. Additionally, technological advancements in compounding—such as 3D printing and advanced mixing systems—are enhancing medication precision and safety. The market is alsexpanding intinnovative delivery formats like transdermal gels and flavored suspensions, and diversifying across a broader range of animals including exotic pets and livestock.

Key Market Drivers

Growing Pet Ownership and Awareness of Animal Health

The United States Animal Drug Compounding Market is growing significantly due ta notable rise in pet ownership and heightened awareness around animal healthcare. As of 2024, 66% of U.S. households, or approximately 86.9 million homes, own at least one pet—up from 56% in 1988. Alongside this trend, pet owners are increasingly committed tmaintaining their animals’ health, reflected in higher spending on veterinary care, medications, and wellness products. For example, pet-related expenditures reached USD 89 billion in 2023, including a 16% jump in pet food sales. This increased attention tpet well-being is driving demand for personalized veterinary solutions. Compounded medications, which address specific medical conditions and treatment needs, are gaining traction as more pet owners seek tailored healthcare options unavailable through conventional pharmaceuticals.

Key Market Challenges

Limited Awareness and Education

A significant hurdle for the United States Animal Drug Compounding Market is the general lack of awareness and education about compounded veterinary medications. Many veterinarians are not fully informed about how compounded drugs can effectively manage complex health conditions in animals. This knowledge gap, especially prevalent in areas dominated by traditional pharmaceutical use, limits the broader adoption of compounding solutions. Additionally, pet owners often remain unaware of the benefits and availability of such treatments, partly due ttheir low visibility in standard veterinary practices and pharmacies. Although veterinary schools are beginning tincorporate compounding inttheir curricula, more comprehensive education is needed tensure future professionals are equipped trecommend and administer these medications confidently. Regulatory awareness is alslimited, with agencies like the FDA still in early stages of promoting compounded drug safety and guidelines—further hindering widespread market uptake.

Key Market Trends

Increased Demand for Personalized Veterinary Medicine

A key trend propelling growth in the United States Animal Drug Compounding Market is the rising demand for personalized veterinary care. As pets are increasingly seen as family members, there is a stronger expectation for healthcare solutions that are tailored teach animal’s individual needs. Compounded drugs allow for modification in dosage strength, form, and flavor tbetter suit specific medical requirements—whether for chronic illnesses, allergies, or age-related conditions. This capability is especially valuable for treating animals that respond poorly toff-the-shelf medications. Customized treatments such as flavored oral suspensions for picky pets or hypoallergenic formulas for animals with sensitivities improve adherence and outcomes. The movement toward personalized care mirrors broader healthcare trends in precision medicine and is gaining traction as veterinarians and pet owners seek more targeted, effective treatment strategies for a diverse range of animal patients.

Key Market Players

• Wedgewood Pharmacy LLC
• Triangle Compounding Pharmacy Inc.
• Diamondback Drugs, LLC
• Medisca Inc.
• Essential Pharmacy Compounding Veterinary
• Millers Pharmacy, Inc.
• Custom Med Compounding Pharmacy, Inc.
• Davis Islands Pharmacy, Inc.
• Wellness Pharmacy of Cary, Inc.
• Cencora, Inc.

Report Scope:

In this report, the United States Animal Drug Compounding Market has been segmented intthe following categories, in addition tthe industry trends which have alsbeen detailed below:

• United States Animal Drug Compounding Market, By Product:
• Anti-infective Agents
• Anti-inflammatory Agents
• Hormones & Substitutes
• CNS Agents
• Others
• United States Animal Drug Compounding Market, By Animal Type:
• Companion Animal
• Livestock Animal
• United States Animal Drug Compounding Market, By Route of Administration:
• Oral
• Injectable
• Topical
• Others
• United States Animal Drug Compounding Market, By Region:
• North-East
• Mid-West
• West
• South

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the United States Animal Drug Compounding Market.

Available Customizations:

United States Animal Drug Compounding Market report with the given market data, TechSci Research offers customizations according ta company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up tfive).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Product (Anti-infective Agents, Anti-inflammatory Agents, Hormones & Substitutes, CNS Agents, Others)
  5.2.2. By Animal Type (Companion Animal, Livestock Animal)
  5.2.3. By Route of Administration (Oral, Injectable, Topical, Others)
  5.2.4. By Region
  5.2.5. By Company (2024)
5.3. Market Map

6. NORTH-EAST ANIMAL DRUG COMPOUNDING MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Product
  6.2.2. By Animal Type
  6.2.3. By Route of Administration

7. MID-WEST ANIMAL DRUG COMPOUNDING MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Product
  7.2.2. By Animal Type
  7.2.3. By Route of Administration

8. WEST ANIMAL DRUG COMPOUNDING MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Product
  8.2.2. By Animal Type
  8.2.3. By Route of Administration

9. SOUTH ANIMAL DRUG COMPOUNDING MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Product
  9.2.2. By Animal Type
  9.2.3. By Route of Administration

10. MARKET DYNAMICS

10.1. Drivers
10.2. Challenges

11. MARKET TRENDS & DEVELOPMENTS

11.1. Merger & Acquisition (If Any)
11.2. Product Launches (If Any)
11.3. Recent Developments

12. POLICY & REGULATORY LANDSCAPE

13. UNITED STATES ECONOMIC PROFILE

14. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET: SWOT ANALYSIS

15. PORTER’S FIVE FORCES ANALYSIS

15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Products

16. COMPETITIVE LANDSCAPE

16.1. Wedgewood Pharmacy LLC
  16.1.1. Business Overview
  16.1.2. Company Snapshot
  16.1.3. Products & Services
  16.1.4. Financials (As Reported)
  16.1.5. Recent Developments
  16.1.6. Key Personnel Details
  16.1.7. SWOT Analysis
16.2. Triangle Compounding Pharmacy Inc.
16.3. Diamondback Drugs, LLC
16.4. Medisca Inc.
16.5. Essential Pharmacy Compounding Veterinary
16.6. Millers Pharmacy, Inc.
16.7. Custom Med Compounding Pharmacy, Inc.
16.8. Davis Islands Pharmacy, Inc.
16.9. Wellness Pharmacy of Cary, Inc.
16.10. Cencora, Inc.

17. STRATEGIC RECOMMENDATIONS

18. ABOUT US & DISCLAIMER